Capricor Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 11.1M | 2.3M | 4.0M |
| Cost of Goods Sold | 0 | 0 | 20.4M | 22.0M | 18.9M | 14.6M | 11.8M | 12.5M |
| Gross Profit | 0 | 0 | -20.4M | -22.0M | -18.9M | -3.4M | -9.5M | -8.5M |
| R&D Expenses | 27.4M | 23.1M | 20.4M | 22.0M | 18.9M | 14.6M | 11.8M | 12.5M |
| Operating Expenses | 36.8M | 29.2M | 5.9M | 5.7M | 6.1M | 4.3M | 3.5M | 3.1M |
| Operating Income | -36.8M | -29.2M | -26.3M | -27.7M | -25.0M | -7.7M | -13.0M | -11.6M |
| Other Income / Gains | 2.8M | -1.0M | 1.7M | 1.8M | 591K | 581K | 453K | 591K |
| Net Income | -33.9M | -30.2M | -24.6M | -25.9M | -24.4M | -7.1M | -12.6M | -11.0M |
| EPS (Diluted) | -0.59 | -0.62 | -0.54 | -0.57 | -0.53 | -0.16 | -0.38 | -0.35 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | -0.308 | -4.221 | -2.149 |
| General And Administrative Expenses | 9.1M | 0 | 5.9M | 5.7M | 6.1M | 4.3M | 3.5M | 3.1M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 9.1M | 6.0M | 5.9M | 5.7M | 6.1M | 4.3M | 3.5M | 3.1M |
| Other Expenses | 253K | 0 | -20.4M | -22.0M | -18.9M | -14.6M | -11.8M | -12.5M |
| Cost And Expenses | 36.8M | 29.2M | 26.3M | 27.7M | 25.0M | 18.8M | 15.3M | 15.6M |
| Interest Income | 2.9M | 2.0M | 1.7M | 1.8M | 730K | 687K | 453K | 591K |
| Interest Expense | 0 | 3.0M | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 535K | 1.00B | 495K | 486K | 405K | 376K | 361K | 357K |
| Ebitda | -33.4M | 976.2M | -24.1M | -25.4M | -24.0M | -6.7M | -12.2M | -10.6M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | -0.606 | -5.392 | -2.68 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | -0.692 | -5.752 | -2.919 |
| Income Before Tax | -33.9M | -30.2M | -24.6M | -25.9M | -24.4M | -7.1M | -12.6M | -11.0M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | -0.639 | -5.552 | -2.77 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | -0.639 | -5.552 | -2.77 |
| Epsdiluted | -0.59 | -0.62 | -0.54 | -0.57 | -0.53 | -0.16 | -0.38 | -0.35 |
| Weighted Average Shs Out | 57.4M | 48.9M | 45.7M | 45.7M | 45.6M | 35.2M | 33.1M | 31.8M |
| Weighted Average Shs Out Dil | 57.4M | 48.9M | 45.7M | 45.7M | 45.6M | 35.2M | 33.1M | 31.8M |